Odyssey Therapeutics, Inc.

US$19.23As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ODTXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$921.9M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$25
28.50%
(67.93%)
Hold 1|10|4|4|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.21
0.20
0.20
0.22
(0.68%)
(1.73%)
(0.03%)
2.90%
Revenue$M
45.10
44.10
43.93
44.30
1.23%
(2.27%)
(1.79%)
2.04%
Peers (US$921.9M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.231
0.289
0.292
EBIT/Intx
0.427
0.082
0.088
Own earn%
61.04
11.85
10.41
Sh yield%
26.11
18.99
19.00
Owners
Insiders/Inst%
12.96
70.12
Short interest%
5.90
SBC / revenue%
2.17
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
19–24
$1 testx
−0.2
Incr. ROIC%
0